‘NRG-GU001: Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer’ of page ‘NRG-GU001’
NRG-GU001 PowerPoint Presentation Letter to Potential Site Investigators Principal Investigator Libni Eapen, MD, FRCPC Primary Objective To evaluate the ability of post-cystectomy adjuvant radiotherapy to reduce pelvic tumor recurrence Patient Population Patients with pT3 / pT4 pN0-2 urothelial ( pure urothelial or primary urothelial mixed with other subtypes) bladder cancer following radical cystectomy with […]
Read More